Published in Harefuah on November 01, 1983
Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature (1990) 1.99
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study. Circulation (1983) 1.06
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood (1993) 0.97
Multiple brain abscesses caused by Streptococcus bovis. J Infect (1991) 0.93
The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med (1998) 0.93
Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim Biophys Acta (1986) 0.91
Additive antianginal effect of verapamil in patients receiving propranolol. Br Med J (Clin Res Ed) (1982) 0.86
Hyponatremia in myxedema: a suggested therapeutic approach. Isr J Med Sci (1979) 0.86
Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia. J Clin Invest (1997) 0.86
Abnormal erythrocyte calcium homeostasis in oxidant-induced hemolytic disease. Blood (1981) 0.84
Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis (1999) 0.83
First trimester listeriosis with normal fetal outcome. Eur J Clin Microbiol Infect Dis (1994) 0.83
Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes. Blood (1993) 0.83
Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum (1993) 0.83
Impaired erythrocyte calcium homeostasis in beta-thalassemia. Blood (1984) 0.82
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Br Med J (Clin Res Ed) (1984) 0.82
Near-fatal systemic oxygen embolism due to wound irrigation with hydrogen peroxide. Postgrad Med J (1982) 0.81
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency. Acta Haematol (1985) 0.81
Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity. J Lab Clin Med (1999) 0.81
Hemolytic anemia as a complication of acute viral hepatitis in glucose-6-phosphate dehydrogenase-deficient and healthy individuals. Isr J Med Sci (1983) 0.81
The origin of sickle cell alleles in Israel. Hum Genet (1990) 0.81
Calcium transport and ultrastructure of red cells in beta-thalassemia intermedia. Blood (1988) 0.80
[A national qualifying internal medicine examination for Israeli medical students]. Harefuah (1995) 0.79
Dexamethasone for acute radiation encephalopathy. Lancet (1978) 0.79
Erythrocyte membrane alterations in beta-thalassaemia. Clin Haematol (1985) 0.79
Tumour of the nose as a presenting feature of leukaemia. J Laryngol Otol (1982) 0.79
Failure of propranolol to improve exercise tolerance in patients with mitral stenosis in sinus rhythm. Br Heart J (1987) 0.78
Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): evidence for DFO as an extracellular inducer of oxidant stress in RBC. Am J Hematol (2000) 0.78
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect. Circulation (1982) 0.78
Risk indicators after envenomation in humans by Echis coloratus (mid-east saw scaled viper). Toxicon (1992) 0.76
Thrombotic thrombocytopenic purpura associated with Bacteroides bacteremia. Arch Intern Med (1981) 0.76
Methyldopa-induced immune hemolytic anemia and chronic active hepatitis. Arch Intern Med (1983) 0.75
Reversal of lactic acidosis associated with heart failure by nitroprusside administration. Br Med J (1979) 0.75
Gout and amyloidosis. Ann Rheum Dis (1980) 0.75
Hamartoma of the spleen. A case report. Isr J Med Sci (1978) 0.75
The spectrum of parathyroid function in thalassaemia subjects with transfusional iron overload. Miner Electrolyte Metab (1982) 0.75
[New therapeutic approaches to Paget's disease of bone]. Harefuah (1980) 0.75
Intracerebral tumor and diffuse central nervous system infiltration complicating acute myelogenous leukemia. Cancer (1979) 0.75
Primaquine-induced superoxide production by beta-thalassemic red blood cells. Biochim Biophys Acta (1992) 0.75
Hyporeninemic hypoaldosteronism associated with focal glomerular sclerosis in a patient with chronic lymphocytic leukemia. Nephron (1982) 0.75
Severe facial oedema and glossitis associated with mianserin. Lancet (1989) 0.75
[Treatment with beta-blockers after myocardial infarction improves the long term prognosis]. Harefuah (1982) 0.75
Envenomation by Echis coloratus (Mid-East saw-scaled viper): a review of the literature and indications for treatment. Isr J Med Sci (1993) 0.75
Erythrocyte (Ca+2 + Mg+2)-ATPase activity: increased sensitivity to oxidative stress in glucose-6-phosphate dehydrogenase deficiency. Am J Hematol (1985) 0.75
Improved prognosis during long-term treatment with beta-blockers after myocardial infarction: analysis of randomized trials and pooling of results. Heart Lung (1984) 0.75
Clinical relevance of gestational thrombocytopenia of < 100,000/microliters. Am J Hematol (1994) 0.75
Methyldopa-induced thrombocytopenia in chronic lymphocytic leukemia. N Engl J Med (1977) 0.75
Myelofibrosis in young adults. Acta Haematol (1983) 0.75
Treatment of envenomation by Echis coloratus (mid-east saw scaled viper): a decision tree. Toxicon (1989) 0.75
Masked phenytoin-induced megaloblastic anemia in beta-thalassemia minor. Acta Haematol (1987) 0.75
[Perhexilene maleate--a new drug for the treatment of angina pectoris]. Harefuah (1978) 0.75
Erythrocyte (Ca2+ + Mg2+)-ATPase activity and calcium homeostasis in Duchenne muscular dystrophy. J Neurol Sci (1984) 0.75
Posttransfusion thrombocytopenia. Isr J Med Sci (1988) 0.75
[Paget's disease--diagnostic and therapeutic aspects]. Harefuah (1982) 0.75
Erythrocyte 22Na+ influx in hypertension. Clin Exp Hypertens A (1984) 0.75
[Hemoglobin A1 c and evaluation of balance and complications of diabetes]. Harefuah (1978) 0.75
Alterations in structure, function, and Ca++ content of thalassemic red blood cells. Biomed Biochim Acta (1983) 0.75
Eosinophilia associated with acute allograft kidney rejection. Nephron (1982) 0.75
Corrigendum: Growth and modelling of spherical crystalline morphologies of molecular materials. Nat Commun (2015) 0.75
[Hoffman's syndrome]. Harefuah (1986) 0.75
[Castleman's disease]. Harefuah (1986) 0.75
[Secondary prevention of myocardial infarction with beta-blockers: for how many?]. Harefuah (1987) 0.75
[Central nervous system involvement in acute myelogenous leukemia]. Harefuah (1979) 0.75
[Amiodarone pulmonary toxicity]. Harefuah (1987) 0.75
[Hereditary disorders of the skeleton of the red cell membrane]. Harefuah (1992) 0.75
[Vitamin B12 deficiency in megaloblastic anemia in vegans]. Harefuah (1982) 0.75
Primary fibrinogenolysis complicating second trimester placental separation. Arch Gynecol Obstet (1992) 0.75
Chronic granulocytic leukemia in pregnancy. A case report and review of the literature. Acta Obstet Gynecol Scand (1980) 0.75
[Paget's disease of bone]. Harefuah (1981) 0.75
[Viper envenomation by Echis coloratus]. Harefuah (1991) 0.75
Pseudo-Pelger-Huët anomaly in chronic lymphocytic leukemia. Acta Haematol (1981) 0.75
Erythrocyte hexose monophosphate shunt is intact in healthy aged humans. Clin Physiol Biochem (1988) 0.75
Phenytoin-induced arthritis. Neurology (1982) 0.75